Phathom Pharmaceuticals, Inc. PHAT Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s total equity?
- Phathom Pharmaceuticals, Inc. (PHAT) reported total equity of -$336.96M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s total equity changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s total equity increased by 0.4% year-over-year, from -$338.38M to -$336.96M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s total equity?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s total equity has grown at a 17.7% compound annual growth rate (CAGR), from $194.27M to -$438.17M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.